273 related articles for article (PubMed ID: 9717843)
1. Functional interactions of the AF-2 activation domain core region of the human androgen receptor with the amino-terminal domain and with the transcriptional coactivator TIF2 (transcriptional intermediary factor2).
Berrevoets CA; Doesburg P; Steketee K; Trapman J; Brinkmann AO
Mol Endocrinol; 1998 Aug; 12(8):1172-83. PubMed ID: 9717843
[TBL] [Abstract][Full Text] [Related]
2. Human androgen receptor mutation disrupts ternary interactions between ligand, receptor domains, and the coactivator TIF2 (transcription intermediary factor 2).
Lim J; Ghadessy FJ; Abdullah AA; Pinsky L; Trifiro M; Yong EL
Mol Endocrinol; 2000 Aug; 14(8):1187-97. PubMed ID: 10935543
[TBL] [Abstract][Full Text] [Related]
3. Functional in vivo interaction between the amino-terminal, transactivation domain and the ligand binding domain of the androgen receptor.
Doesburg P; Kuil CW; Berrevoets CA; Steketee K; Faber PW; Mulder E; Brinkmann AO; Trapman J
Biochemistry; 1997 Feb; 36(5):1052-64. PubMed ID: 9033395
[TBL] [Abstract][Full Text] [Related]
4. A novel mutation F826L in the human androgen receptor in partial androgen insensitivity syndrome; increased NH2-/COOH-terminal domain interaction and TIF2 co-activation.
Wong HY; Hoogerbrugge JW; Pang KL; van Leeuwen M; van Royen ME; Molier M; Berrevoets CA; Dooijes D; Dubbink HJ; van de Wijngaart DJ; Wolffenbuttel KP; Trapman J; Kleijer WJ; Drop SL; Grootegoed JA; Brinkmann AO
Mol Cell Endocrinol; 2008 Sep; 292(1-2):69-78. PubMed ID: 18656523
[TBL] [Abstract][Full Text] [Related]
5. Beta-catenin binds to the activation function 2 region of the androgen receptor and modulates the effects of the N-terminal domain and TIF2 on ligand-dependent transcription.
Song LN; Herrell R; Byers S; Shah S; Wilson EM; Gelmann EP
Mol Cell Biol; 2003 Mar; 23(5):1674-87. PubMed ID: 12588987
[TBL] [Abstract][Full Text] [Related]
6. Oligospermic infertility associated with an androgen receptor mutation that disrupts interdomain and coactivator (TIF2) interactions.
Ghadessy FJ; Lim J; Abdullah AA; Panet-Raymond V; Choo CK; Lumbroso R; Tut TG; Gottlieb B; Pinsky L; Trifiro MA; Yong EL
J Clin Invest; 1999 Jun; 103(11):1517-25. PubMed ID: 10359561
[TBL] [Abstract][Full Text] [Related]
7. Mutational analysis of the androgen receptor AF-2 (activation function 2) core domain reveals functional and mechanistic differences of conserved residues compared with other nuclear receptors.
Slagsvold T; Kraus I; Bentzen T; Palvimo J; Saatcioglu F
Mol Endocrinol; 2000 Oct; 14(10):1603-17. PubMed ID: 11043576
[TBL] [Abstract][Full Text] [Related]
8. Domain interactions between coregulator ARA(70) and the androgen receptor (AR).
Zhou ZX; He B; Hall SH; Wilson EM; French FS
Mol Endocrinol; 2002 Feb; 16(2):287-300. PubMed ID: 11818501
[TBL] [Abstract][Full Text] [Related]
9. Distinct recognition modes of FXXLF and LXXLL motifs by the androgen receptor.
Dubbink HJ; Hersmus R; Verma CS; van der Korput HA; Berrevoets CA; van Tol J; Ziel-van der Made AC; Brinkmann AO; Pike AC; Trapman J
Mol Endocrinol; 2004 Sep; 18(9):2132-50. PubMed ID: 15178743
[TBL] [Abstract][Full Text] [Related]
10. Interaction between the amino- and carboxyl-terminal regions of the rat androgen receptor modulates transcriptional activity and is influenced by nuclear receptor coactivators.
Ikonen T; Palvimo JJ; Jänne OA
J Biol Chem; 1997 Nov; 272(47):29821-8. PubMed ID: 9368054
[TBL] [Abstract][Full Text] [Related]
11. Androgen receptor ligand-binding domain interaction and nuclear receptor specificity of FXXLF and LXXLL motifs as determined by L/F swapping.
Dubbink HJ; Hersmus R; Pike AC; Molier M; Brinkmann AO; Jenster G; Trapman J
Mol Endocrinol; 2006 Aug; 20(8):1742-55. PubMed ID: 16627595
[TBL] [Abstract][Full Text] [Related]
12. Functional analysis of a novel androgen receptor mutation, Q902K, in an individual with partial androgen insensitivity.
Umar A; Berrevoets CA; Van NM; van Leeuwen M; Verbiest M; Kleijer WJ; Dooijes D; Grootegoed JA; Drop SL; Brinkmann AO
J Clin Endocrinol Metab; 2005 Jan; 90(1):507-15. PubMed ID: 15486055
[TBL] [Abstract][Full Text] [Related]
13. Differential modulation of androgen receptor transcriptional activity by the nuclear receptor co-repressor (N-CoR).
Berrevoets CA; Umar A; Trapman J; Brinkmann AO
Biochem J; 2004 May; 379(Pt 3):731-8. PubMed ID: 14744261
[TBL] [Abstract][Full Text] [Related]
14. Ligand- and coactivator-mediated transactivation function (AF2) of the androgen receptor ligand-binding domain is inhibited by the cognate hinge region.
Wang Q; Lu J; Yong EL
J Biol Chem; 2001 Mar; 276(10):7493-9. PubMed ID: 11102454
[TBL] [Abstract][Full Text] [Related]
15. The presence of both the amino- and carboxyl-terminal domains in the AR is essential for the completion of a transcriptionally active form with coactivators and intranuclear compartmentalization common to the steroid hormone receptors: a three-dimensional imaging study.
Saitoh M; Takayanagi R; Goto K; Fukamizu A; Tomura A; Yanase T; Nawata H
Mol Endocrinol; 2002 Apr; 16(4):694-706. PubMed ID: 11923466
[TBL] [Abstract][Full Text] [Related]
16. The use of androgen receptor amino/carboxyl-terminal interaction assays to investigate androgen receptor gene mutations in subjects with varying degrees of androgen insensitivity.
Ghali SA; Gottlieb B; Lumbroso R; Beitel LK; Elhaji Y; Wu J; Pinsky L; Trifiro MA
J Clin Endocrinol Metab; 2003 May; 88(5):2185-93. PubMed ID: 12727974
[TBL] [Abstract][Full Text] [Related]
17. Evidence for an anti-parallel orientation of the ligand-activated human androgen receptor dimer.
Langley E; Zhou ZX; Wilson EM
J Biol Chem; 1995 Dec; 270(50):29983-90. PubMed ID: 8530400
[TBL] [Abstract][Full Text] [Related]
18. The androgen receptor amino-terminal domain plays a key role in p160 coactivator-stimulated gene transcription.
Alen P; Claessens F; Verhoeven G; Rombauts W; Peeters B
Mol Cell Biol; 1999 Sep; 19(9):6085-97. PubMed ID: 10454556
[TBL] [Abstract][Full Text] [Related]
19. Roles of steroid receptor coactivator (SRC)-1 and transcriptional intermediary factor (TIF) 2 in androgen receptor activity in mice.
Ye X; Han SJ; Tsai SY; DeMayo FJ; Xu J; Tsai MJ; O'Malley BW
Proc Natl Acad Sci U S A; 2005 Jul; 102(27):9487-92. PubMed ID: 15983373
[TBL] [Abstract][Full Text] [Related]
20. An investigation into CAG repeat length variation and N/C terminal interactions in the T877A mutant androgen receptor found in prostate cancer.
Southwell J; Chowdhury SF; Gottlieb B; Beitel LK; Lumbroso R; Purisima EO; Trifiro M
J Steroid Biochem Mol Biol; 2008 Jul; 111(1-2):138-46. PubMed ID: 18619542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
